drugset / Trial / NCT00323947
Methylphenidate for Treating Attention Deficit Hyperactivity Disorder in Children With Both ADHD and Epilepsy
Phase 4
Completed
33 enrolled
Boston Children's Hospital
National Institute of Mental Health (NIMH) · collab
RandomizedCrossoverQuadruple-blindTreatment
Summary
This study will evaluate the safety and effectiveness of extended release methylphenidate (XR-MPH) in treating attention deficit hyperactivity disorder (ADHD) in children with both ADHD and epilepsy.
Timeline
- Start
- 2003-05
- Primary completion
- 2007-11
- Completion
- 2007-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Methylphenidate | Small molecule | 18 mg | — |
| Comparator | Methylphenidate | Small molecule | 36 mg | — |
| Comparator | Methylphenidate | Small molecule | 54 mg | — |